Trial · NCT07909824
Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces-Universidad Rey Juan Carlos (URJC)
NCT07909824, Not yet recruiting, Universidad Rey Juan Carlos
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces-Universidad Rey Juan Carlos (URJC). Trials, record NCT07909824. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909824
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces-Universidad Rey Juan Carlos (URJC)
- NCT number
- NCT07909824
- Status
- Not yet recruiting
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Universidad Rey Juan Carlos
- Conditions
- Neurologic Disorders
- Interventions
- NeurEYE: healthy people, NeurEYE: people with neurological diseases
- First posted
- 2026-11-02
- Last updated
- 2026-11-04
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cognitive assessment | First year | Rivermead Behavioural Memory Test (RBMT) is a standardized memory assessment tool designed to evaluate how memory problems affect a person's daily functioning. It primarily assesses prospective memory, verbal memory, visual memory, recognition, and orientation through tasks that simulate everyday situations. It is a widely used test in clinical and research settings, with adequate psychometric properties (reliability and validity) and sensitivity for detecting memory impairments associated with brain damage, neurodegenerative diseases, and other neurological conditions. It is administered individually by a trained professional. It includes various functional tasks, such as recalling names, routes, messages, or personal belongings. |
| Primary | Grip strength assessment | First year | To measure grip strength the Jamar dynamometer is a standardized instrument used to measure handgrip strength, a relevant indicator of upper limb muscle function and overall functional status. It is frequently used in rehabilitation, neurology, geriatrics, and musculoskeletal assessment. It is considered the gold standard for grip strength assessment. It exhibits high reliability, validity, and reproducibility, making it widely used in both clinical practice and research. |
| Primary | Manual dexterity | First year | The Nine Hole Peg Test (NHPT) is a standardized test used to assess fine motor dexterity and upper limb motor coordination. It measures how quickly a person can place and remove nine pegs from a pegboard and is widely used in neurology and rehabilitation. It is a well-validated tool with good reliability, validity, and sensitivity for detecting changes in manual function. It is frequently used in research and clinical practice with populations affected by stroke, multiple sclerosis, Parkinson's disease, and other neurological conditions. |
| Primary | Cognitive abilities | First year | The Trail Making Test (TMT) is a standardized neuropsychological test that assesses processing speed, visual attention, cognitive flexibility, and executive functions. It can be administered by occupational therapists. It consists of two parts: Part A involves connecting numbers in sequence, and Part B involves alternating numbers and letters in a predetermined order. It is one of the most widely used and validated tests in neuropsychology. It exhibits adequate psychometric properties, good reliability, and sensitivity for detecting cognitive impairments associated with brain damage, aging, dementia, and other neurological diseases. |
| Primary | Language | First year | The Quick Aphasia Battery (QAB) is an standardized tool designed to quickly assess the presence and severity of language impairments in individuals with aphasia. It evaluates various language domains, including auditory comprehension, verbal expression, repetition, naming, reading, and language fluency. It is a validated test with good psychometric properties, allowing for the reliable identification and quantification of language deficits. It has proven useful in both clinical and research settings, particularly in patients with stroke and other acquired neurological injuries. |
| Primary | Behavioral | First Year | Lille Apathy Rating Scale (LARS) is a standardized tool designed to assess apathy in individuals with neurological disorders. It analyzes different dimensions of this syndrome, including motivation, interest, initiative, participation in activities, and emotional response. It is a widely used and validated scale, especially in Parkinson's disease and other neurological conditions. It exhibits good internal consistency, high inter-rater reliability, and adequate construct and criterion validity, allowing for the reliable identification and quantification of apathy severity. |
| Primary | Depression | First year | Mini-DASS (Mini Depression Anxiety Stress Scales). Designed to assess emotional distress across three main dimensions: depression, anxiety, and stress. It is used as a screening tool to identify emotional symptoms and monitor changes over time. It is a measure based on the theoretical model of the Depression Anxiety Stress Scales, which has been widely validated in general and clinical populations. The abbreviated versions have shown adequate validity and reliability, maintaining a good ability to discriminate between depressive, anxious, and stress symptoms. Good internal consistency for the total score and its subscales, with Cronbach's alpha coefficients generally above 0.70. Adequate convergent validity with other measures of depression, anxiety, and emotional well-being. Good sensitivity for detecting mild, moderate, and high levels of psychological distress. A factor structure consistent with the dimensions of depression, anxiety |
| Primary | Apraxia | First Year | Test of Upper Limb Apraxia (TULIA). This is a standardized tool designed to assess upper limb apraxia, that is, difficulties in planning and executing learned movements voluntarily despite preserving basic strength, sensation, and comprehension. It evaluates the imitation and execution of both transitive (object use) and intransitive (communicative) movements. It is a widely validated test for the assessment of apraxia following stroke and other neurological injuries. It exhibits high reliability, validity, and discriminative power, making it one of the reference tools for the clinical and research assessment of upper limb apraxia. |
| Primary | Attentional deficit | First Year | Star Cancellation Test is a screening test used to assess unilateral spatial hemineglect, a common impairment following brain injury, especially after a right hemisphere stroke. It evaluates a person's ability to visually explore space and identify stimuli distributed on a sheet of paper. It is one of the most widely used tests for detecting spatial hemineglect. It has demonstrated good clinical validity and sensitivity for identifying visuospatial attention deficits, and is included in widely used batteries in neurology and neurorehabilitation, such as the Behavioral Inattention Test (BIT). |
| Primary | Sensibility 1 | First year | Algometry (pressure pain threshold measurement) is a standardized technique used to assess sensitivity to mechanical pain by measuring the pressure pain threshold (PPT). It allows for the objective quantification of the minimum pressure that elicits a painful sensation and is frequently used in patients with musculoskeletal disorders, chronic pain, and neurological conditions. Algometry is a widely used method in research and clinical practice for pain assessment. It exhibits good validity and reliability when performed with standardized protocols, and is particularly useful for monitoring changes in pain sensitivity and response to treatments. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Cancellation Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909824
GET https://conductscience.org/api/trials/v1/NCT07909824/registered